Lifordi Immunotherapeutics Funding: $70M Raised, Series A
Lifordi Immunotherapeutics is a Biotech company based in Burlington, MA. It has raised $70M in total funding. Latest round: Series A.
Lifordi Immunotherapeutics funding overview
Lifordi Immunotherapeutics is a Biotech company based in Burlington, MA. Lifordi Immunotherapeutics has raised $70M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2024. The round record for Lifordi Immunotherapeutics runs through 2024; nothing later has been disclosed. Investors on record include ARCH Venture Partners, 5AM Ventures, Atlas Venture. 3 distinct backers are named across the disclosed rounds.
Frequently asked about Lifordi Immunotherapeutics funding
How much has Lifordi Immunotherapeutics raised?
Lifordi Immunotherapeutics has raised $70M in total disclosed funding across the rounds on record.
Who has invested in Lifordi Immunotherapeutics?
ARCH Venture Partners, 5AM Ventures, Atlas Venture are named among the investors backing Lifordi Immunotherapeutics.
What was the latest Lifordi Immunotherapeutics funding round?
The most recent disclosed round is a Series A, announced in September 2024.
Where is Lifordi Immunotherapeutics based?
Lifordi Immunotherapeutics is based in Burlington, MA.
What sector does Lifordi Immunotherapeutics operate in?
Lifordi Immunotherapeutics is tracked under Biotech from Burlington, MA, with $70M in disclosed funding.
When did Lifordi Immunotherapeutics last raise?
The last disclosed Lifordi Immunotherapeutics round closed in September 2024 at Series A.
Every Lifordi Immunotherapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Burlington at a similar stage.
Companies related to Lifordi Immunotherapeutics (40)
